Market News Today — AI-Curated Stock & Crypto Headlines

The FDA has decided not to add a black box warning to Covid-19 vaccines, citing changes in the vaccines since their initial release.

The US FDA has announced plans to reduce the use of primate testing in drug trials, aligning with the Trump administration's goal to lower pharmaceutical costs.

The Bloomberg Markets episode discusses market trends with guests from RobinHood and Bloomberg, but does not provide specific information on the FDA's new vaccine requirements or their market impact.

Moderna's stock price fell due to the FDA's plan to impose new restrictions on vaccine approvals, potentially impacting the company's future vaccine releases.

Moderna stock fell in premarket trading after the FDA announced plans to impose new vaccine requirements, potentially impacting the company's future vaccine releases.

FinBERT analysis of financial text showing neutral sentiment with 87.5% confidence.

Markets are preparing for a wave of economic data following the US government reopening, which may impact market sentiment and trading decisions.

The FDA has removed strict warning labels from hormone replacement therapies, allowing drugmakers to rebrand them without black box warnings, potentially increasing their appeal to women.

The US FDA has promoted Richard Pazdur to a top position, aiming to boost staff morale and improve relations with the pharmaceutical industry, amidst unrest in the agency's top ranks.

UniQure NV shares declined after the FDA deemed the clinical data for its experimental gene-therapy for Huntington's disease as insufficient, leading to a potential delay in the drug's approval.